WebDr Bhatias Neuropain Medical Center 736 E Bullard Ave Ste 101 Fresno, CA 93710 (559) 437-9700 OVERVIEW PHYSICIANS AT THIS PRACTICE PHYSICIANS AT Dr Bhatias Neuropain Medical Center Showing 1-9 of... WebDr Bhatias Neuropain Medical Center 736 E Bullard Ave Ste 101, Fresno, CA, 93710 2 other locations (559) 437-9700 OVERVIEW Dr. Bhatia graduated from the Government Medical College Amritsar in...
Dr. Perminder Bhatia, MD Neurology in Fresno, CA Healthline …
WebApr 6, 2024 · Dr. Perminder Bhatia is a certified Neurologist, Principal Investigator for Clinical Trials and Director at Neuro Pain Medical Center. He completed his MBBS from … Clinical trials are conducted in a series of steps, called phases – each phase is … For appointment, medical records, refills, billing or clinical research, please contact … A neurologist is a physician specializing in neurology and trained to investigate, or … Fresno migraine specialist Dr Bhatia’s Neuro Pain Medical Center located on … Dr. Bhatia, MD. Research Coordinator. Isha Monga. Research Coordinator. Mandeep … Dr. Bhatia and the rest of the staff in Fresno have been wonderful throughout their … Fresno migraine specialist Dr Bhatia’s Neuro Pain Medical Center located on … Web42 customer reviews of Dr. Perminder Bhatia, MD. One of the best Doctors, Healthcare business at 736 E Bullard Ave #101, Fresno CA, 93710 United States. Find Reviews, Ratings, Directions, Business Hours, Contact Information and book online appointment. chase in el monte
TESTIMONIALS - Neuro Pain Medical Center, Fresno
WebDr. Perminder Bhatia, MD is a Neurology Specialist in Fresno, CA. They graduated from GURU NANAK DEV UNIVERSITY / MEDICAL COLLEGE and is affiliated with Saint Agnes … WebServices Perminder Bhatia provides internal medicine in Fresno, CA. Perminder Bhatia is listed as an internist, which is a physician who studies Internal Medicine for adults. To learn more, or to make an appointment with Perminder Bhatia in Fresno, CA, please call (530) 790-4000. Consumer Feedback ( 1 Review) View All Reviews Add a Review WebJan 10, 2024 · Official Title: A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Flexible-Dose, 27-Week Trial to Evaluate the Efficacy, Safety, and Tolerability of Tavapadon in Early Parkinson's Disease (TEMPO-2 Trial) Actual Study Start Date : January 6, 2024. Estimated Primary Completion Date : October 2024. curves nsw